Dr. Robin Oshman, MD

NPI: 1497832554
Total Payments
$944.62
2023 Payments
$61.99
Companies
7
Transactions
10

Payment Breakdown by Category

Food & Beverage$794.62 (84.1%)
Other$150.00 (15.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $794.62 9 84.1%
Honoraria $150.00 1 15.9%

Top Paying Companies

Company Total Records Latest Year
EPI Health, LLC $312.94 2 $0 (2018)
Amgen Inc. $158.72 2 $0 (2019)
Galderma Laboratories, L.P. $147.27 1 $0 (2018)
DERMIRA, INC. $125.00 1 $0 (2019)
Ortho Dermatologics, a division of Bausch Health US, LLC $77.34 1 $0 (2019)
Incyte Corporation $77.33 2 $0 (2023)
Celgene Corporation $46.02 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $61.99 1 Incyte Corporation ($61.99)
2022 $15.34 1 Incyte Corporation ($15.34)
2019 $248.56 3 DERMIRA, INC. ($125.00)
2018 $506.23 4 EPI Health, LLC ($312.94)
2017 $112.50 1 Amgen Inc. ($112.50)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/16/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $61.99 General
Category: Dermatology
12/03/2022 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $15.34 General
Category: Dermatology
12/07/2019 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $46.22 General
Category: Inflammation
09/26/2019 DERMIRA, INC. QBREXZA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: DERMATOLOGY
03/02/2019 Ortho Dermatologics, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $77.34 General
08/21/2018 EPI Health, LLC Bensal HP (Drug), Nuvail, Sitavig 50mg Honoraria Cash or cash equivalent $150.00 General
Category: Dermatology
08/08/2018 EPI Health, LLC Bensal HP (Drug), Nuvail, Sitavig 50mg Food and Beverage Cash or cash equivalent $162.94 General
Category: Dermatology
02/17/2018 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $46.02 General
Category: Dermatology
02/16/2018 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $147.27 General
03/05/2017 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $112.50 General
Category: Inflammation

About Dr. Robin Oshman, MD

Dr. Robin Oshman, MD is a Dermatology healthcare provider based in Westport, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497832554.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Oshman, MD has received a total of $944.62 in payments from pharmaceutical and medical device companies, with $61.99 received in 2023. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($794.62).

Practice Information

  • Specialty Dermatology
  • Location Westport, CT
  • Active Since 11/01/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1497832554

Products in Payments

  • Bensal HP (Drug) $312.94
  • Enbrel (Biological) $158.72
  • QBREXZA (Drug) $125.00
  • OPZELURA (Drug) $77.33
  • Otezla (Drug) $46.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Westport